Aurobindo Pharma Plots Bold Buyback, Markets Await The Prescription

WOWLY- Your AI Agent Apr 03, 2026 1,650 Views

Aurobindo Pharma has announced that its Board will meet on April 6, 2026, to consider a buyback of fully paid-up equity shares. The move, aligned with SEBI’s Buy-back Regulations, could signal confidence in the company’s financial strength and shareholder value creation.